These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 18927960)

  • 1. Treatment of juvenile spasticity with botulinum toxin type A.
    Desloovere K; Molenaers G
    Nervenarzt; 2008 Jun; 79 Suppl 1():19-21. PubMed ID: 18927960
    [No Abstract]   [Full Text] [Related]  

  • 2. Botulinum toxin for cerebral palsy; where are we now?
    Morton RE; Hankinson J; Nicholson J
    Arch Dis Child; 2004 Dec; 89(12):1133-7. PubMed ID: 15557051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin type A and dynamic equinus in children with cerebral palsy: new indication. Better than repeat casts.
    Prescrire Int; 2001 Feb; 10(51):12-4. PubMed ID: 11503850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Upper extremity botulinum toxin treatment in cerebral palsy. Treatment guidelines the first step towards national cooperation].
    Arner M; Himmelmann K; Pontén E; Stankovic N; Hansson T; Dahlin LB
    Lakartidningen; 2008 Oct 22-28; 105(43):3009-13. PubMed ID: 19024613
    [No Abstract]   [Full Text] [Related]  

  • 5. Botulinum toxin type A in the management of cerebral palsy: low or high dose?
    Dai AI
    Pediatr Neurol; 2006 Dec; 35(6):446; author reply 447. PubMed ID: 17138019
    [No Abstract]   [Full Text] [Related]  

  • 6. Botulinum toxin A injection for children with spastic cerebral palsy.
    YaJie W; BaoQin G
    Dev Med Child Neurol; 2008 Aug; 50(8):640. PubMed ID: 18754907
    [No Abstract]   [Full Text] [Related]  

  • 7. Re: Botulinum neurotoxin A: an unusual systemic effect 43 (2007) 499-501.
    Scheinberg A; O'Flaherty S; Waugh MC; Baxter A; Gurd K
    J Paediatr Child Health; 2008; 44(7-8):468-9; author reply 469. PubMed ID: 18638338
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of a multimodal management of prematurity-related spasticity.
    Papavasiliou AS; Rapidi CA; Filiopoulos C; Rizou C; Skouteli HN
    Pediatr Neurol; 2006 Dec; 35(6):400-7. PubMed ID: 17138009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Multidisciplinary therapy for focal spasticity treatment].
    Wissel J
    Nervenarzt; 2008 Jun; 79 Suppl 1():24-8. PubMed ID: 18927962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Botulinum toxin treatment of spastic cerebral palsy].
    Hansen LK; Pedersen NR; Westphall IT; Pedersen LT; Jensen H; Villads A
    Ugeskr Laeger; 2004 Aug; 166(34):2888-90. PubMed ID: 15449526
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term efficacy and tolerability of 4-monthly versus yearly botulinum toxin type A treatment for lower-limb spasticity in children with cerebral palsy.
    Kanovský P; Bares M; Severa S; Richardson A;
    Dev Med Child Neurol; 2009 Jun; 51(6):436-45. PubMed ID: 19563586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of multilevel botulinum toxin a and comprehensive rehabilitation on gait in cerebral palsy.
    Scholtes VA; Dallmeijer AJ; Knol DL; Speth LA; Maathuis CG; Jongerius PH; Becher JG
    Pediatr Neurol; 2007 Jan; 36(1):30-9. PubMed ID: 17162194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How do we treat pediatric patients with spastic diplegia?
    Dai AI
    Pediatr Phys Ther; 2006; 18(4):306; author reply 306-7. PubMed ID: 17108805
    [No Abstract]   [Full Text] [Related]  

  • 14. Prospective study examining remote effects of botulinum toxin a in children with cerebral palsy.
    Crowner BE; Racette BA
    Pediatr Neurol; 2008 Oct; 39(4):253-8. PubMed ID: 18805363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the effectiveness of botulinum toxin injections in the lower limb muscles of children with cerebral palsy. Preliminary prospective study of the advantages of ultrasound guidance.
    Py AG; Zein Addeen G; Perrier Y; Carlier RY; Picard A
    Ann Phys Rehabil Med; 2009 Apr; 52(3):215-23. PubMed ID: 19447084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of adductor spasticity with BTX-A in children with CP: a randomized, double-blind, placebo-controlled study.
    Mall V; Heinen F; Siebel A; Bertram C; Hafkemeyer U; Wissel J; Berweck S; Haverkamp F; Nass G; Döderlein L; Breitbach-Faller N; Schulte-Mattler W; Korinthenberg R
    Dev Med Child Neurol; 2006 Jan; 48(1):10-3. PubMed ID: 16359588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Botulinum toxin in infantile cerebral palsy].
    Póo P; Galván-Manso M; Casartelli MJ; López-Casas J; Gassió-Subirats RM; Blanco C; Terricabras-Carol L
    Rev Neurol; 2008; 47 Suppl 1():S21-4. PubMed ID: 18767013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Botulinum toxin: a new dimension for spasticity].
    Reichel G
    MMW Fortschr Med; 2007 May; 149 Suppl 2():65-9. PubMed ID: 17724971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin type A with oral baclofen versus oral tizanidine: a nonrandomized pilot comparison in patients with cerebral palsy and spastic equinus foot deformity.
    Dai AI; Wasay M; Awan S
    J Child Neurol; 2008 Dec; 23(12):1464-6. PubMed ID: 19073853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized controlled trial to compare two botulinum toxin injection techniques on the functional improvement of the leg of children with cerebral palsy.
    Kaishou Xu ; Tiebin Yan ; Jianning Mai
    Clin Rehabil; 2009 Sep; 23(9):800-11. PubMed ID: 19482892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.